The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells

Journal of Oral Pathology and Medicine

Volumn 40, Issue 7, 2011, Pages 525-532

  Du, Guan Huan ^a   Qin, Xiao Peng ^a   Li, Qin ^a   Zhou, Yong Mei ^a   Shen, Xue Min ^a   Tang, Guo Yao ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Immune regulation; Oral lichen planus; Programmed death 1 ligands

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANTIBODIES; ANTIGEN PRESENTATION; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; COLORING AGENTS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-2; KERATINOCYTES; LICHEN PLANUS, ORAL; LYMPHOCYTE ACTIVATION; MOUTH MUCOSA; PHYTOHEMAGGLUTININS; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 79960634980     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01035.x     Document Type: Article

References (34)

1. Plege A, Bornsk K, Baars W, Schwinzer R. Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands. Transplantation 2009; 87: 975-82.
2. Bretscher PA. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci USA 1999; 96: 185-90.
3. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445-80.
4. Vincenti F, Luggen M. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu Rev Med 2007; 58: 347-58.
5. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008; 121: 299-306.
6. Carreno BM, Colline M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29-53.
7. Khoury SJ, Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004; 20: 529-38.
8. Rieta C, Chen L. New B7 family members with positive and negative costimulatory function. Am J Transplant 2004; 4: 8-14.
9. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006; 27: 195-201.
10. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704.
11. Tseng SY, Otsuji M, Gorski K, et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193: 839-46.
12. Wang J, Okazaki IM, Yoshida T, et al. PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol 2010; 22: 443-52.
13. Menke J, Lucas JA, Zeller GC, et al. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J Immunol 2007; 179: 7466-77.
14. Shin T, Kennedy G, Gorski K, et al. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1receptor. J Exp Med 2003; 198: 31-8.
15. Shin T, Yoshimura K, Shin T, et al. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med 2005; 201: 1531-41.
16. Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765-72.
17. Scully C, Elsen D, Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol 2000; 1: 287-306.
18. Carrozzo M, Uboldi de Capei M, Dametto E, et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004; 122: 87-94.
19. Carrozzo M, Thorpe R. Oral lichen planus: a review. Minerva Stomatol 2009; 58: 519-37.
20. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010; 28: 100-8.
21. Bagan JV, Thongprasom K, Scully C. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. Oral Dis 2004; 10: 401-3.
22. Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007; 49: 89-106.
23. Thornhill MH, Pemberton MN, Simmons RK, Theaker ED. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 291-9.
24. Youngnak--Piboonratanakit P, Tsushima F, Otsuki N, et al. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol Lett 2004; 94: 215-22.
25. van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003; 32: 507-12.
26. -ΔΔCt method. Methods 2001; 25: 402-8.
27. Imaizumi F, Asahina I, Moriyama T, Ishii M, Omura K. Cultured mucosal cell sheet with a double layer of keratinocytes and fibroblasts on a collagen membrane. Tissue Eng 2004; 10: 657-64.
28. Pfistershammer K, Klauser C, Pickl WF, et al. No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation. Eur J Immunol 2006; 36: 1104-13.
29. Okudaira K, Hokari R, Tsuzuki Y, et al. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model. Int J Oncol 2009; 35: 741-9.
30. Akbari O, Stock P, Singh AK, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010; 3: 81-91.
31. Liu X, Gao JX, Wen J, et al. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 2003; 197: 1721-30.
32. Heckman KL, Schenk EL, Radhakrishnan S, Pavelko KD, Hansen MJ, Pease LR. Fast-tracked CTL: rapid induction of potent antitumor killer T cells in situ. Eur J Immunol 2007; 37: 1827-35.
33. Van Keulen VP, Ciric B, Radhakrishnan S, et al. Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12. Clin Exp Immunol 2006; 143: 314-21.
34. Simark-Mattsson C, Bergenholta G, Jontell M, et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499-507.